Investment Thesis
iSpecimen exhibits severe fundamental deterioration with collapsing profitability, negative cash flows, and acute liquidity distress. The company operates at massive losses (-335% operating margin) while burning cash, with a current ratio of 0.63x indicating insufficient short-term liquidity to cover immediate obligations.
Strengths
- Maintains positive cash balance of $2.8M providing short-term runway
- Asset base of $9.0M provides liquidation floor
- Recently reported data ensures metrics reflect current state
Risks
- Critical liquidity crisis with current ratio of 0.63x and negative operating cash flow of -$3.3M quarterly
- Revenue declining 6.4% YoY while operating losses expand significantly
- Unsustainable burn rate: negative free cash flow of -$3.3M per quarter will deplete cash reserves within 9 months at current burn rates
- Debt/Equity ratio of 1.12x with $3.4M long-term debt and negative earnings create refinancing risk
- No insider purchasing activity in 90 days signals loss of management confidence
- Negative interest coverage of -349.4x indicates inability to service debt from operations
Key Metrics to Watch
- Quarterly cash burn rate and remaining cash runway
- Revenue stabilization and path to positive operating cash flow
- Gross margin sustainability and operating expense reduction initiatives
- Current ratio trend and working capital management
- Debt covenant compliance and refinancing needs
Financial Metrics
Revenue
1.9M
Net Income
-5.5M
EPS (Diluted)
$-1.54
Free Cash Flow
-3.3M
Total Assets
9.0M
Cash
2.8M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-335.1%
Net Margin
-292.3%
ROE
-178.5%
ROA
-61.0%
FCF Margin
-177.1%
Balance Sheet & Liquidity
Current Ratio
0.63x
Quick Ratio
0.63x
Debt/Equity
1.12x
Debt/Assets
65.8%
Interest Coverage
-349.45x
Long-term Debt
3.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-29T14:22:12.297667 |
Data as of: 2025-09-30 |
Powered by Claude AI